Sugi Predict

Sugi Predict / Compounds / SCHEMBL2159809

SCHEMBL2159809

SCHEMBL2159809

COc1ccccc1OCCCNC(=O)[C@@H]1C[C@H](C)CC[C@H]1C(C)C

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 1/20 0.54
▸ TRPM8 Q7Z2W7 4/20 0.52
▸ MTNR1A P48039 1/20 0.47
▸ MTNR1B P49286 1/20 0.47
▸ HPGD P15428 1/20 0.43
▸ PDE4A P27815 2/20 0.43
▸ PDE4B Q07343 2/20 0.43
▸ PDE4C Q08493 2/20 0.43
▸ PDE4D Q08499 2/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ HTR1A P08908 5/20 0.43
▸ ADRA1D P25100 5/20 0.43
▸ ADRA1A P35348 5/20 0.43
▸ ADRA1B P35368 5/20 0.43
▸ EPHX1 P07099 1/20 0.42
▸ TRPV1 Q8NER1 1/20 0.42
▸ NPC1 O15118 1/20 0.42
▸ HSP90AA1 P07900 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2159792 0.90 TRPM8 (0.47) KMT2ATRPM8ALDH1A1EPHX1
SCHEMBL2628688 0.84 HPGD (0.53) KMT2ATRPM8MTNR1AMTNR1BHPGD
SCHEMBL2159887 0.83 NPC1 (0.53) KMT2ATRPM8MTNR1AMTNR1BHPGD
SCHEMBL2160155 0.82 TRPM8 (0.50) KMT2ATRPM8HPGDALDH1A1HTR1A
SCHEMBL24540470 0.82 TRPM8 (0.44) KMT2ATRPM8MTNR1AMTNR1BHPGD
SCHEMBL24540436 0.82 TRPM8 (0.44) KMT2ATRPM8MTNR1AMTNR1BHPGD
SCHEMBL24540639 0.81 MTNR1A (0.46) KMT2ATRPM8MTNR1AMTNR1BHPGD
SCHEMBL24540761 0.81 TRPM8 (0.44) KMT2ATRPM8MTNR1AMTNR1BHPGD
SCHEMBL24540633 0.81 TRPM8 (0.45) KMT2ATRPM8MTNR1AMTNR1BHPGD
SCHEMBL24540361 0.80 TRPM8 (0.44) KMT2ATRPM8MTNR1AMTNR1BHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8377422-B2 Carboxamide derivatives having cooling properties GIVAUDAN S.A. (CH) 2013-02-19 — — US claimed
US-20110182833-A1 Carboxamide Derivatives Having Cooling Properties GIVAUDAN SA (CH) 2011-07-28 — — US claimed
EP-2229352-A2 CARBOXAMIDE DERIVATIVES HAVING COOLING PROPERTIES Givaudan SA (CH) 2010-09-22 — — EP claimed
WO-2009070910-A2 CARBOXAMIDE DERIVATIEVES HAVING COOLING PROPERTIES GIVAUDAN SA (CH) 2009-06-11 — — WO claimed
US-8377422-B2 Carboxamide derivatives having cooling properties GIVAUDAN S.A. (CH) 2013-02-19 — — US disclosed
US-20110182833-A1 Carboxamide Derivatives Having Cooling Properties GIVAUDAN SA (CH) 2011-07-28 — — US disclosed
EP-2229352-A2 CARBOXAMIDE DERIVATIVES HAVING COOLING PROPERTIES Givaudan SA (CH) 2010-09-22 — — EP disclosed
WO-2009070910-A2 CARBOXAMIDE DERIVATIEVES HAVING COOLING PROPERTIES GIVAUDAN SA (CH) 2009-06-11 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110182833-A1 Carboxamide Derivatives Having Cooling Properties CPS1, NQO2, NDUFA2 KMT2A 1195/4885TRPM8 376/4885MTNR1A 424/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.